Nephron Pharmaceuticals Overview

Life ScienceCompany

Was Nephron Pharmaceuticals formerly PE-backed?

Yes. Nephron Pharmaceuticals was formerly owned by 1 private investor.

Where is Nephron Pharmaceuticals headquartered?

Nephron Pharmaceuticals is headquartered in West Columbia, South Carolina.

What sector is Nephron Pharmaceuticals in?

Nephron Pharmaceuticals is a life science company.

When was Nephron Pharmaceuticals founded?

Nephron Pharmaceuticals was founded in 1937.

Nephron Pharmaceuticals

Nephron Pharmaceuticals Corp.

4500 12th Street Extension,
West Columbia, South Carolina 29172
United States,
(803) 569-2800
www.nephronpharm.com

Nephron Pharmaceutical is a privately owned manufacturer of generic inhalation solutions. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area. Nephron Pharmaceuticals was founded in 1937 and is based in West Columbia, South Carolina.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.